JUNE 24, 2009--Michelson Diagnostics Ltd. (MDL; Orpington, UK) has opened a U.S. sales and support office in Fuquay-Varina, NC, in the Research Triangle vicinity of Raleigh-Durham. The office is headed by Kevin C. Oakley, Michelson's new Business Development Manager (US). The office will act as a hub for growth of MDL's business in the field of optical coherence tomography (OCT) imaging.
OCT has great applications potential in fields such as skin cancer diagnosis, genetics research and tissue engineering development. In fact, Michelson has demonstrated its handheld-probe system for skin imaging at recent trade shows. The company has no FDA-approved clinical products yet, but is selling an OCT microscope for the scientific research market and recently announced the VivoSight in-vivo OCT system, for which it expects clinical approvals to be granted in Europe imminently.
"We already have US sales and are experiencing rapid growth of US enquiries in multiple market segments," said Jon Holmes, CEO of Michelson Diagnostics Ltd, "so it makes sense for us to establish a US presence to enable us to pursue these opportunities more effectively and to provide US customers with local support and service."
Oakley, is an experienced medical imaging executive with a background in expanding markets and growing sales for small companies with highly innovative medical imaging products. His career includes senior executive positions at Richardson Electronics Ltd. (Medical SBU), InfiMed, Inc., Lodox Systems, Ltd., and TeraRecon Inc.
For further information contact Oakley at [email protected] or +1 (315) 783-3803, or visit Michelson Diagnostics' website.
Posted by Barbara G. Goode, [email protected], for BioOptics World.